Loading...
XSWX
MEDX
Market cap434mUSD
Apr 09, Last price  
9.11CHF
1D
-2.04%
1Q
-11.04%
IPO
-79.39%
Name

medmix AG

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.77
EPS
—
Div Yield, %
5.49%
Shrs. gr., 5y
0.98%
Rev. gr., 5y
2.84%
Revenues
484m
-0.55%
454,000,000420,700,000351,300,000457,300,000477,100,000486,600,000483,900,000
Net income
-7m
L
52,200,00025,200,0009,600,00044,000,00011,600,000300,000-7,400,000
CFO
87m
+54.37%
94,200,00089,100,00050,600,00087,300,00047,600,00056,100,00086,600,000
Dividend
Apr 26, 20240.5 CHF/sh

Profile

Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.
URL
https://www.medmix.ch
IPO date
Sep 30, 2021
Employees
2,245
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
483,900
-0.55%
486,600
1.99%
477,100
4.33%
Cost of revenue
466,000
473,600
428,300
Unusual Expense (Income)
NOPBT
17,900
13,000
48,800
NOPBT Margin
3.70%
2.67%
10.23%
Operating Taxes
2,200
600
Tax Rate
16.92%
1.23%
NOPAT
17,900
10,800
48,200
Net income
(7,400)
-2,566.67%
300
-97.41%
11,600
-73.64%
Dividends
(15,000)
(15,000)
(15,000)
Dividend yield
3.93%
1.92%
2.07%
Proceeds from repurchase of equity
(500)
(3,100)
295,500
BB yield
0.13%
0.40%
-40.85%
Debt
Debt current
20,900
42,200
164,100
Long-term debt
367,500
378,400
380,900
Deferred revenue
4,600
Other long-term liabilities
25,600
27,400
(100)
Net debt
292,200
276,600
225,000
Cash flow
Cash from operating activities
86,600
56,100
47,600
CAPEX
(38,500)
(46,400)
(38,600)
Cash from investing activities
(51,500)
(80,600)
(57,000)
Cash from financing activities
(48,600)
(153,800)
116,100
FCF
31,700
(12,500)
23,500
Balance
Cash
96,200
130,600
316,800
Long term investments
13,400
3,200
Excess cash
72,005
119,670
296,145
Stockholders' equity
509,600
588,800
517,300
Invested Capital
723,695
731,830
680,355
ROIC
2.46%
1.53%
7.17%
ROCE
2.20%
1.49%
4.92%
EV
Common stock shares outstanding
43,333
41,204
41,100
Price
8.80
-53.68%
19.00
7.95%
17.60
-61.03%
Market cap
381,333
-51.29%
782,870
8.23%
723,360
-61.04%
EV
683,833
1,118,070
948,360
EBITDA
79,500
68,400
99,900
EV/EBITDA
8.60
16.35
9.49
Interest
12,000
10,100
6,500
Interest/NOPBT
67.04%
77.69%
13.32%